CLINICAL_TRIALS trial_result · 2023-08-14

Clinical Trial Update: Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ruxolitinib for sclerotic chronic graft-versus-host disease after failure of systemic glucocorticoids has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: University of Nebraska | Conditions: Graft-versus-host-disease (GVHD) | Phase 2 | Status: COMPLETED | Results posted: 2023-08-14